Abolishing multidrug resistance in cultured lung cancer cells with RNA interference

作者: Kamal Prajapati

DOI:

关键词:

摘要:

参考文章(118)
Scott W. Lowe, Athena W. Lin, APOPTOSIS IN CANCER Carcinogenesis. ,vol. 21, pp. 485- 495 ,(2000) , 10.1093/CARCIN/21.3.485
Howard F. Tiano, Patricia C. Chulada, Morrow B. Thompson, Joel F. Mahler, Robert Langenbach, Christopher Lee, Christine M. Doyle, Oliver Smithies, Scott G. Morham, Beth W. Gaul, Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice Cancer Research. ,vol. 60, pp. 4705- 4708 ,(2000)
E. Wiemer, V. A. Kickhoefer, A. B. Schroeijers, D. F. Dukers, G. L. Scheffer, J. W. Slootstra, L. H. Rome, S. C. E. Bolick, R. J. Scheper, M. C. De Jong, R. H. Meloen, A. C. Siva, The Mr 193,000 Vault Protein Is Up-Regulated in Multidrug-resistant Cancer Cell Lines Cancer Research. ,vol. 60, pp. 1104- 1110 ,(2000)
John K. Wiencke, David C. Christiani, Karl T. Kelsey, John C. Wain, T. J. Cheng, Eugene Mark, Xiping Xu, Xi Wang, Michael Fischbein, Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiology and Prevention Biomarkers. ,vol. 4, pp. 543- 548 ,(1995)
D. Schreiber, J. Rineer, D. Vongtama, A. Kim, A. Wortham, P. Han, K. Choi, M. Rotman, Surgery for limited-stage small cell lung cancer, should the paradigm shift? A SEER-based analysis Journal of Clinical Oncology. ,vol. 26, pp. 7525- 7525 ,(2008) , 10.1200/JCO.2008.26.15_SUPPL.7525
Patricia V. Schoenlein, Role of gene amplification in drug resistance Cancer treatment and research. ,vol. 73, pp. 167- 200 ,(1994) , 10.1007/978-1-4615-2632-2_9
K M Murphy, V Ranganathan, M L Farnsworth, M Kavallaris, R B Lock, Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death & Differentiation. ,vol. 7, pp. 102- 111 ,(2000) , 10.1038/SJ.CDD.4400597
Oshika Y, Kijima H, Tsuchida T, Abe Y, Hatanaka H, Inoue H, Katoh Y, Yamazaki H, Ueyama Y, Nakamura M, A case of pulmonary adenocarcinoma with overexpression of multidrug resistance-associated protein and p53 aberration. Anticancer Research. ,vol. 20, pp. 1921- 1925 ,(2000)
Robert F. Ozols, Lori J. Goldstein, Anticancer Drug Resistance ,(2012)